Neuralink’s attempt for the brand “risks” and “moves” face legal issues

US Patent and brands office rejected Neuralink’s Try for a brand brand product names and satellite stirring, citing requests suspended by someone else for the same brands.

Neuralink, brain transplantation company was established Elon MuskHe presented to The brand names in March. But in the messages sent to Neuralink in August, the brands office refuses to allow applications to move forward. We Wesley Perry, the computer world and the founder of the prophetic prophetic company for technology, was previously presented to the risk applications in May 2023 and the sad effects in August 2024. The prophecy adopts headphones that can be worn to urge the clear dream, but only Perry is the author of the brand applications, not the prophet. (Perry refused to comment on this story.)

In response to the Neuralink application of risk, the brand office also refers to the current brand of risk laboratories, a company based in Tampa that provides audio technology and interactive chat.

At the same time, Musk’s Neuralink The computer’s computer interface It includes a device, surgically planted in the skull, combining brain activity. The company uses the name of the risk to describe its first product, which was designed to allow the paralyzed persons to operate their phones and computers with their ideas only. Musk revealed the name of the risk in January 2024 Social media yetSoon after the company’s planting The first volunteer With technology. There are now a total of nine people Neuralink, according to July announcement. (Neuralink did not respond to the comment.)

Berry and Neuralink submitted “intention to use” requests, which allow companies and inventors to book brand rights before using the brand in trade. Perry was a risk request I accepted in December 2024 And to move In August 2025 But the brands are not fully registered until it appears that it is already using them in trade. Perry has three years to do so, otherwise his requests will be considered deserted and the Neuralink application will take priority.

Berry has not marketed a product or markets it called Telepathy or Telekinesis, but in its commercial applications it describes as “an EEG program to decode the internal dialogue to control mobile devices or mobile devices.” EEG data, or the electrical brain chart, indicates the electrical activity of the registered brain through the electric electrodes that are worn on the scalp.

Brands Office messages to Neuralink are not the final decisions. Neuralink presented a response speech on August 28, dealing with the current laboratory brand, saying that Neuralink is not likely to be confused with risk laboratories. Neuralink did not address Berry applications in their response.

“The standard for the possibility of confusion is, if a random consumer faces these two producers, do they think they come from the same company?” Heather Antoine, an intellectual property partner in Stop Reeves in Sacramento, California.

The brands office will consider the Neuralink response and decide whether there is a possibility of confusion. But there is still the fact that Perry has submitted a request to record signs of abandonment and the transformation standard first. If Perry succeeds in registering signs, Neuralink will have some options. You can try to buy brands from Berry or negotiate the approval agreement, as Berry can agree to allow Neuralink to use the marks as well. These types of agreements are usually made when brands do not cause consumer disturbance.

If Berry succeeds in recording the risk, Neuralink can be sued if the company continues to use it.

Josh Genben, the brand lawyer and the founder of Genben Elbeb in Washington, DC, says it is difficult to know how things will fade because there is a lot of accuracy in the brand’s demand. “Certainly at the present time, an advantage goes to this other applicant,” he says. “It can become a big thorn on the Neuralink side in terms of these brands.”